Theravance Biopharma, Inc. (21) | Uncategorized (7)

Recent Contracts

Audited financial statements of Theravance Respiratory Company, LLC for the year ended December 31, 2021 (Filed With SEC on February 28, 2022)
Offer Letter with Richard Graham August 12, 2015 (Filed With SEC on November 9, 2020)
Brett K. Haumann Transfer to Theravance Biopharma UK Ltd. Memo (Filed With SEC on May 8, 2020)
Brett K. Haumann Theravance Biopharma UK Ltd. Contract of Employment (Filed With SEC on May 8, 2020)
First Amendment of Registration Rights Agreement with Glaxo Group Limited (Filed With SEC on May 8, 2020)
Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)
Offer Letter with Andrew Hindman dated May 30, 2019 (Filed With SEC on August 5, 2019)